Carrizzo A - Search Results

1

Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF.

Visco V, Radano I, Campanile A, Ravera A, Silverio A, Masarone D, Pacileo G, Correale M, Mazzeo P, Dattilo G, Giallauria F, Cuomo A, Mercurio V, Tocchetti CG, Di Pietro P, Carrizzo A, Citro R, Galasso G, Vecchione C, Ciccarelli M. Visco V, et al. Among authors: carrizzo a. ESC Heart Fail. 2022 Oct;9(5):2909-2917. doi: 10.1002/ehf2.13982. Epub 2022 Jun 15. ESC Heart Fail. 2022. PMID: 35702942 Free PMC article.

2

Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity.

Puca AA, Carrizzo A, Ferrario A, Villa F, Vecchione C. Puca AA, et al. Among authors: carrizzo a. Immun Ageing. 2012 Nov 15;9(1):26. doi: 10.1186/1742-4933-9-26. Immun Ageing. 2012. PMID: 23153280 Free PMC article.

3

Vascular ageing: the role of oxidative stress.

Puca AA, Carrizzo A, Villa F, Ferrario A, Casaburo M, Maciąg A, Vecchione C. Puca AA, et al. Among authors: carrizzo a. Int J Biochem Cell Biol. 2013 Mar;45(3):556-9. doi: 10.1016/j.biocel.2012.12.024. Epub 2013 Jan 7. Int J Biochem Cell Biol. 2013. PMID: 23305730 Review.

4

Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism.

Carrizzo A, Puca A, Damato A, Marino M, Franco E, Pompeo F, Traficante A, Civitillo F, Santini L, Trimarco V, Vecchione C. Carrizzo A, et al. Hypertension. 2013 Aug;62(2):359-66. doi: 10.1161/HYPERTENSIONAHA.111.01009. Epub 2013 Jun 10. Hypertension. 2013. PMID: 23753407

5

Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.

Carrizzo A, Forte M, Damato A, Trimarco V, Salzano F, Bartolo M, Maciag A, Puca AA, Vecchione C. Carrizzo A, et al. Food Chem Toxicol. 2013 Nov;61:215-26. doi: 10.1016/j.fct.2013.07.021. Epub 2013 Jul 18. Food Chem Toxicol. 2013. PMID: 23872128 Review.

6

Nitric oxide dysregulation in platelets from patients with advanced Huntington disease.

Carrizzo A, Di Pardo A, Maglione V, Damato A, Amico E, Formisano L, Vecchione C, Squitieri F. Carrizzo A, et al. PLoS One. 2014 Feb 25;9(2):e89745. doi: 10.1371/journal.pone.0089745. eCollection 2014. PLoS One. 2014. PMID: 24587005 Free PMC article.

7

Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases.

Carrizzo A, Forte M, Lembo M, Formisano L, Puca AA, Vecchione C. Carrizzo A, et al. Curr Drug Targets. 2014;15(13):1231-46. doi: 10.2174/1389450115666141027110156. Curr Drug Targets. 2014. PMID: 25345393 Review.

8

Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases.

Conti V, Forte M, Corbi G, Russomanno G, Formisano L, Landolfi A, Izzo V, Filippelli A, Vecchione C, Carrizzo A. Conti V, et al. Among authors: carrizzo a. Curr Drug Targets. 2017;18(4):473-484. doi: 10.2174/1389450116666151019095903. Curr Drug Targets. 2017. PMID: 26477463 Review.

9

Brain diseases and tumorigenesis: The good and bad cops of pentraxin3.

Fornai F, Carrizzo A, Ferrucci M, Damato A, Biagioni F, Gaglione A, Puca AA, Vecchione C. Fornai F, et al. Among authors: carrizzo a. Int J Biochem Cell Biol. 2015 Dec;69:70-4. doi: 10.1016/j.biocel.2015.10.017. Epub 2015 Oct 17. Int J Biochem Cell Biol. 2015. PMID: 26485684 Review.

10

Cyclin D1 Gene Silencing by siRNA in Ex Vivo Human Tissue Cultures.

Piazza O, Russo I, Bochicchio S, Barba AA, Lamberti G, Zeppa P, Crescenzo VD, Carrizzo A, Vecchione C, Ciacci C. Piazza O, et al. Among authors: carrizzo a. Curr Drug Deliv. 2017;14(2):246-252. doi: 10.2174/1567201813666160512150710. Curr Drug Deliv. 2017. PMID: 27174173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page